A Pilot Study of Lenalidomide Maintenance Therapy in Stage IIIB/IV Non-small Cell Lung Cancer After First-line Chemotherapy

Trial Profile

A Pilot Study of Lenalidomide Maintenance Therapy in Stage IIIB/IV Non-small Cell Lung Cancer After First-line Chemotherapy

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 14 Apr 2016

At a glance

  • Drugs Lenalidomide (Primary)
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 11 Apr 2016 Status changed from recruiting to active, no longer recruiting.
    • 14 Jul 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 24 Feb 2014 Planned initiation date changed from 1 Feb 2014 to 1 Apr 2014 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top